Literature DB >> 12456890

Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.

Suet Y Leung1, Xin Chen, Kent M Chu, Siu T Yuen, Jonathan Mathy, Jiafu Ji, Annie S Y Chan, Rui Li, Simon Law, Olga G Troyanskaya, I-Ping Tu, John Wong, Samuel So, David Botstein, Patrick O Brown.   

Abstract

We analyzed gene expression patterns in human gastric cancers by using cDNA microarrays representing approximately equal 30,300 genes. Expression of PLA2G2A, a gene previously implicated as a modifier of the Apc(Min/+) (multiple intestinal neoplasia 1) mutant phenotype in the mouse, was significantly correlated with patient survival. We confirmed this observation in an independent set of patient samples by using quantitative RT-PCR. Beyond its potential diagnostic and prognostic significance, this result suggests the intriguing possibility that the activity of PLA2G2A may suppress progression or metastasis of human gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456890      PMCID: PMC138589          DOI: 10.1073/pnas.212646299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Nonparametric methods for identifying differentially expressed genes in microarray data.

Authors:  Olga G Troyanskaya; Mitchell E Garber; Patrick O Brown; David Botstein; Russ B Altman
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

2.  Protection by group II phospholipase A2 against Staphylococcus aureus.

Authors:  V J Laine; D S Grass; T J Nevalainen
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

3.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

4.  Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical review.

Authors:  Si-Chun Ming
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 6.  The antibacterial properties of secreted phospholipases A(2).

Authors:  A G Buckland; D C Wilton
Journal:  Biochim Biophys Acta       Date:  2000-10-31

7.  Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris.

Authors:  K Kugiyama; Y Ota; S Sugiyama; H Kawano; H Doi; H Soejima; S Miyamoto; H Ogawa; K Takazoe; H Yasue
Journal:  Am J Cardiol       Date:  2000-10-01       Impact factor: 2.778

8.  Expression of group II phospholipase A2 in the human gastrointestinal tract.

Authors:  T J Nevalainen; J M Grönroos; M Kallajoki
Journal:  Lab Invest       Date:  1995-02       Impact factor: 5.662

9.  In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas.

Authors:  S T Yuen; L P Chung; S Y Leung; I S Luk; S Y Chan; J Ho
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

10.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

Authors:  M MacPhee; K P Chepenik; R A Liddell; K K Nelson; L D Siracusa; A M Buchberg
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

View more
  49 in total

1.  Coexpression analysis of human genes across many microarray data sets.

Authors:  Homin K Lee; Amy K Hsu; Jon Sajdak; Jie Qin; Paul Pavlidis
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

2.  A perspective on DNA microarrays in pathology research and practice.

Authors:  Jonathan R Pollack
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

3.  Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms.

Authors:  Mario Menschikowski; Albert Hagelgans; Eugene Gussakovsky; Heike Kostka; Elena L Paley; Gabriele Siegert
Journal:  Neoplasia       Date:  2008-03       Impact factor: 5.715

4.  Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2.

Authors:  Francescopaolo Granata; Annunziata Frattini; Stefania Loffredo; Rosaria I Staiano; Angelica Petraroli; Domenico Ribatti; Rob Oslund; Michael H Gelb; Gerard Lambeau; Gianni Marone; Massimo Triggiani
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

Review 5.  Cancer evolution and individual susceptibility.

Authors:  Jesús Pérez-Losada; Andrés Castellanos-Martín; Jian-Hua Mao
Journal:  Integr Biol (Camb)       Date:  2011-01-24       Impact factor: 2.192

6.  Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data.

Authors:  Christian Pilarsky; Michael Wenzig; Thomas Specht; Hans Detlev Saeger; Robert Grützmann
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

7.  Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.

Authors:  Hyuk-Joon Lee; Ki Taek Nam; Heae Surng Park; Min A Kim; Bonnie J Lafleur; Hiroyuki Aburatani; Han-Kwang Yang; Woo Ho Kim; James R Goldenring
Journal:  Gastroenterology       Date:  2010-04-13       Impact factor: 22.682

8.  Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.

Authors:  Mario Menschikowski; Albert Hagelgans; Heike Kostka; Graeme Eisenhofer; Gabriele Siegert
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype.

Authors:  Andrew J Syder; Sherif M Karam; Jason C Mills; Joseph E Ippolito; Habib R Ansari; Vidya Farook; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

Review 10.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.